These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 8015945)
1. Dental management of a child on anticoagulant therapy and the International Normalized Ratio: case report. Sheller B; Tong D Pediatr Dent; 1994; 16(1):56-8. PubMed ID: 8015945 [TBL] [Abstract][Full Text] [Related]
2. An assessment of the management of patients on warfarin by general dental practitioners in South West Wales. Muthukrishnan A; Bishop K Br Dent J; 2003 Nov; 195(10):567-70. PubMed ID: 14631427 [TBL] [Abstract][Full Text] [Related]
3. Management of the dental patient on anticoagulant medication. Rada RE Dent Today; 2006 Aug; 25(8):58-63. PubMed ID: 16925162 [No Abstract] [Full Text] [Related]
4. Case report: Patient with acute dental pain has cardiac valve replacement--INR 3.8. What to do? What not to do? Cohen HV; Quek SY; Abbas AM; Figueroa R; Malavia M J N J Dent Assoc; 2012; 83(1):18-20. PubMed ID: 22479779 [TBL] [Abstract][Full Text] [Related]
5. [International normalized ratio (INR) for optimal anticoagulant therapy]. Uetsuka Y; Katsuki T; Aosaki M; Iwade K; Hashimoto A; Koyanagi H; Saito M; Yaginuma Y; Hosoda S Kokyu To Junkan; 1993 Sep; 41(9):885-90. PubMed ID: 8210749 [TBL] [Abstract][Full Text] [Related]
6. What is the INR? Troulis MJ; Head TW; Leclerc JR J Can Dent Assoc; 1996 May; 62(5):428-30. PubMed ID: 8640580 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of the switch from a branded to a generic warfarin sodium product: an observer-blinded, randomized, crossover study. Lee HL; Kan CD; Yang YJ Clin Ther; 2005 Mar; 27(3):309-19. PubMed ID: 15878384 [TBL] [Abstract][Full Text] [Related]
8. Study on warfarin plasma concentration and its correlation with international normalized ratio. Sun S; Wang M; Su L; Li J; Li H; Gu D J Pharm Biomed Anal; 2006 Sep; 42(2):218-22. PubMed ID: 16860509 [TBL] [Abstract][Full Text] [Related]
10. Medical liability risk avoidance: a case for adopting the International Normalized Ratio (INR) system. Kline SS; Atkins MO Am J Manag Care; 1997 Jan; 3(1):59-63. PubMed ID: 10169250 [TBL] [Abstract][Full Text] [Related]
11. Point-of-care monitoring of oral anticoagulation therapy in children. Comparison of the CoaguChek XS system with venous INR and venous INR using an International Reference Thromboplastin preparation (rTF/95). Greenway A; Ignjatovic V; Summerhayes R; Newall F; Burgess J; DeRosa L; Monagle P Thromb Haemost; 2009 Jul; 102(1):159-65. PubMed ID: 19572081 [TBL] [Abstract][Full Text] [Related]
12. Modified anticoagulant therapy factor and international normalized ratio in patients in an unstable coagulation state with respect to warfarin therapy. Carroll WE; Jackson RD Res Commun Mol Pathol Pharmacol; 1999; 105(3):262-70. PubMed ID: 10954130 [TBL] [Abstract][Full Text] [Related]
13. [Role of laboratory monitoring in oral anticoagulant therapy]. D'Angelo G; Calvano D; Giardini C Minerva Med; 1993 Jun; 84(6):313-22. PubMed ID: 8336839 [TBL] [Abstract][Full Text] [Related]
14. Unreliability of international normalized ratio for monitoring warfarin therapy in patients with lupus anticoagulant. Rosborough TK; Shepherd MF Pharmacotherapy; 2004 Jul; 24(7):838-42. PubMed ID: 15303447 [TBL] [Abstract][Full Text] [Related]
15. [An outpatient regimen for dental improvements in patients with valvular cardiopathies and oral anticoagulant therapy (a preliminary note)]. Cesareo BV; Pettini M; Soreca G; Agostino R; Batoni L; Mancini G; Vannini AM; Sabatini L; Bertelli E Minerva Stomatol; 1994 Sep; 43(9):409-15. PubMed ID: 7816015 [TBL] [Abstract][Full Text] [Related]
16. [PT-INR as a parameter for anticoagulant therapy after valve replacement surgery]. Ishibashi Y; Aoki H; Ohba J; Kamikubo Y; Morimoto K; Kumasaka A Kyobu Geka; 1996 Oct; 49(11):906-8. PubMed ID: 8913062 [TBL] [Abstract][Full Text] [Related]
17. International normalized ratio self-management lowers the risk of thromboembolic events after prosthetic heart valve replacement. Eitz T; Schenk S; Fritzsche D; Bairaktaris A; Wagner O; Koertke H; Koerfer R Ann Thorac Surg; 2008 Mar; 85(3):949-54; discussion 955. PubMed ID: 18291177 [TBL] [Abstract][Full Text] [Related]
18. Comparison between CoaguChek S- and Owren-type prothrombin time assay for monitoring anticoagulant therapy. Jonsson M; Hillarp A; Svensson P Thromb Res; 2004; 114(2):83-9. PubMed ID: 15306149 [TBL] [Abstract][Full Text] [Related]
19. Coagulant activity during one year after bioprosthetic aortic valve replacement. Imagawa H; Ryugo M; Shikata F; Nakata T; Nagashima M; Kawachi K Interact Cardiovasc Thorac Surg; 2009 Apr; 8(4):417-20. PubMed ID: 19141491 [TBL] [Abstract][Full Text] [Related]
20. Effect of different oral anticoagulant intensities on prothrombin fragment 1 + 2 in Thai patients with mechanical heart valve prostheses. Tientadakul P; Opartkiattikul N; Sangtawesin W; Sakiyalak P J Med Assoc Thai; 1997 Feb; 80(2):81-6. PubMed ID: 9078691 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]